August Casefinding Reconciliation: Three Borderline Patients
Your 180-bed community hospital is CoC-accredited and accessions roughly 620 analytic cases a year. During an August casefinding reconciliation, your CTR identifies three patients who were never accessioned.
Patient A is a 58-year-old woman with stage IIA breast cancer diagnosed in March at an academic center 200 miles away, where she had a mastectomy and four cycles of chemotherapy. She relocated in June and was seen once in your cancer clinic for a second opinion about continuing adjuvant trastuzumab. Your facility administered nothing, and she returned to the academic center for ongoing care.
Patient B is a 71-year-old man whose CT-guided lung biopsy at your hospital on 12 April showed adenocarcinoma. PET staging was performed at your facility on 18 April. He then traveled to a tertiary center for lobectomy on 3 May, which confirmed the diagnosis and showed two positive hilar nodes.
Patient C is a 63-year-old man who died in your emergency department in July. No autopsy was performed, no tissue was obtained at your facility, and the death certificate lists metastatic carcinoma, primary unknown.
1. For each of the three patients, decide whether the case must be accessioned and whether it is analytic for your CoC program. Show the criteria you applied to each patient.
Read the worked answer
The controlling questions are (1) does the patient have a reportable diagnosis connected to this facility, and (2) did this facility establish the diagnosis or deliver any part of first-course cancer-directed treatment, which is what makes a case analytic under class-of-case rules.
Patient A: no diagnosis and no first-course treatment at your facility. The single second-opinion visit did not initiate or continue cancer-directed therapy, so she is a consult-only, non-analytic patient. Many hospital registries do not accession consult-only cases at all; however, some state central registries require reporting by any facility that sees the patient. Check your state manual before dropping her, and document the decision and its rationale in the casefinding log so a future auditor can follow it.
Patient B: the diagnosis was established by your 12 April biopsy, which makes the case analytic even though the definitive surgery occurred elsewhere. This is the diagnosed-here, treated-elsewhere class of case. The PET performed here strengthens the case for accessioning.
Patient C: a death-certificate-only case with no diagnosis or treatment at your facility. It is reportable to the state as a reportable diagnosis in a resident, and it should be accessioned and flagged DCO. Whether your hospital counts it as analytic depends on your class-of-case policy; most programs treat it as non-analytic because no diagnosis or first-course treatment occurred here. Do not simply discard it.
2. For Patient B, what is the date of diagnosis? How would your answer change if the biopsy report had read atypical cells suspicious for adenocarcinoma instead of adenocarcinoma?
Read the worked answer
With a definitive biopsy, the date of diagnosis for Patient B is 12 April, the date of the first microscopic confirmation of malignancy at your facility. The later lobectomy confirms and stages the disease but does not reset the date.
If the biopsy had said only atypical cells suspicious for adenocarcinoma, the diagnosis would not be definitively established by that specimen. The next step is not to guess but to read the clinical record: did the treating physician document a diagnosis of lung cancer and proceed to surgery on that basis? Under most registry manuals, when a patient is treated as having cancer on the basis of ambiguous terminology, the case becomes reportable, and the date of diagnosis is the date of the first ambiguous diagnosis that prompted treatment, with the outside resection serving as the confirming source. Some manuals instead assign the date of definitive confirmation, so verify this specific rule in your state manual and apply it consistently.
Either way, the case should be queried rather than abandoned. Send a clarification request to the pathologist or treating surgeon asking whether the lesion is considered malignant, record the query and response in the abstract documentation, and only then finalize the date of diagnosis and reportability decision.
3. Patient C is confirmed as a death-certificate-only case. What must the abstract contain, and what follow-back steps are required before you finalize it?
Read the worked answer
A DCO abstract is built from the death certificate and is deliberately sparse. Record the type of reporting source as death certificate only, and use the date of death as the date of diagnosis, which is the standard convention when no diagnostic date exists. Code the primary site from the certificate wording; metastatic carcinoma with unknown primary supports an unknown-primary code, and the histology should be the least specific category the certificate actually supports, such as carcinoma, not a guessed cell type. Stage is unknown. Treatment is none documented. Add a note explaining the basis for each field.
Follow-back comes before finalization. Search the master patient index for prior admissions, emergency visits, and imaging at your facility. Contact the primary care physician, any nursing home, and any outside hospital named in the record to request pathology or oncology records. Check the state death certificate file and any available hospital discharge data for a prior diagnosis. Document every attempt with dates and contacts, because an unfound record and an unsearched record look identical in an audit.
If follow-back produces a tissue diagnosis or treatment record, convert the case to a standard abstract, change the reporting source, and update the date of diagnosis. If nothing is found after a reasonable interval, finalize with unknowns and retain the documentation.